Background Data from a 5-year follow-up of outcomes after transcatheter edge-to-edge
repair of severe mitral regurgitation, as compared with outcomes after maximal doses of …

Patients with heart failure with reduced ejection fraction who have secondary mitral
regurgitation (SMR) have poorer outcomes and quality of life than those without SMR …

Aims Clinical guidelines recommend people with heart failure are managed within a
multidisciplinary team to receive optimal evidence-based management of the syndrome …

Aims In contrast to patient-reported health status measures (such as the Kansas City
Cardiomyopathy Questionnaire), the New York Heart Association class is based on a …

Background Mitral transcatheter edge-to-edge repair (M-TEER) is a guideline-
recommended treatment option for patients with severe symptomatic mitral regurgitation …

The opinions expressed in the Journal item reproduced as this reprint are those of the
authors and contributors, and do not necessarily reflect those of the European Society of …

Despite significant advances in pharmacological, electrophysiological and valve therapies
for heart failure with reduced ejection fraction (HFrEF), the associated morbidity, mortality …

Background. Limited data exist regarding the association between the quality of life (QoL)
and clinical outcomes following transcatheter mitral valve repair (TMVr). We aimed to …

Chronic heart failure (HF) is a clinical syndrome of myocardial dysfunction characterized by
inadequate cardiac output or preserved output that can only be achieved by sustaining …

Background To date, no studies on the feasibility or outcomes of cardiac rehabilitation (CR)
after percutaneous mitral valve reconstruction using clipping procedures have been …